These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22551629)

  • 1. Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
    Barzen S; Rödl CB; Lill A; Steinhilber D; Stark H; Hofmann B
    Bioorg Med Chem; 2012 Jun; 20(11):3575-83. PubMed ID: 22551629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
    Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
    J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
    Hieke M; Rödl CB; Wisniewska JM; la Buscató E; Stark H; Schubert-Zsilavecz M; Steinhilber D; Hofmann B; Proschak E
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1969-75. PubMed ID: 22326163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.
    Lill AP; Rödl CB; Steinhilber D; Stark H; Hofmann B
    Eur J Med Chem; 2015 Jan; 89():503-23. PubMed ID: 25462262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors.
    Tan CM; Chen GS; Chen CS; Chang PT; Chern JW
    Bioorg Med Chem; 2011 Nov; 19(21):6316-28. PubMed ID: 21958737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.
    Suh J; Yum EK; Cheon HG; Cho YS
    Chem Biol Drug Des; 2012 Jul; 80(1):89-98. PubMed ID: 22404847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
    Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
    Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel aminothiazole-comprising 5-LO inhibitors.
    M Kretschmer SB; Woltersdorf S; Rödl CB; Vogt D; Häfner AK; Steinhilber D; Stark H; Hofmann B
    Future Med Chem; 2016; 8(2):149-64. PubMed ID: 26824797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.
    Hofmann B; Rödl CB; Kahnt AS; Maier TJ; Michel AA; Hoffmann M; Rau O; Awwad K; Pellowska M; Wurglics M; Wacker M; Zivković A; Fleming I; Schubert-Zsilavecz M; Stark H; Schneider G; Steinhilber D
    Br J Pharmacol; 2012 Apr; 165(7):2304-13. PubMed ID: 21955369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
    De Lucia D; Lucio OM; Musio B; Bender A; Listing M; Dennhardt S; Koeberle A; Garscha U; Rizzo R; Manfredini S; Werz O; Ley SV
    Eur J Med Chem; 2015 Aug; 101():573-83. PubMed ID: 26197161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.
    Fischer L; Steinhilber D; Werz O
    Br J Pharmacol; 2004 Jul; 142(5):861-8. PubMed ID: 15197110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors.
    Lai Y; Ma L; Huang W; Yu X; Zhang Y; Ji H; Tian J
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7349-53. PubMed ID: 21055929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of EP6--a novel imidazo[1,2-a]pyridine based direct 5-lipoxygenase inhibitor.
    Wisniewska JM; Rödl CB; Kahnt AS; Buscató El; Ulrich S; Tanrikulu Y; Achenbach J; Rörsch F; Grösch S; Schneider G; Cinatl J; Proschak E; Steinhilber D; Hofmann B
    Biochem Pharmacol; 2012 Jan; 83(2):228-40. PubMed ID: 22027220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship and in vitro pharmacological evaluation of imidazo[1,2-a]pyridine-based inhibitors of 5-LO.
    Buscató El; Wisniewska JM; Rödl CB; Brüggerhoff A; Kaiser A; Rörsch F; Kostewicz E; Wurglics M; Schubert-Zsilavecz M; Grösch S; Steinhilber D; Hofmann B; Proschak E
    Future Med Chem; 2013 May; 5(8):865-80. PubMed ID: 23682565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
    Hieke M; Greiner C; Thieme TM; Schubert-Zsilavecz M; Werz O; Zettl H
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1329-33. PubMed ID: 21310608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure based drug design, synthesis and evaluation of 4-(benzyloxy)-1-phenylbut-2-yn-1-ol derivatives as 5-lipoxygenase inhibitors.
    Reddy NP; Chandramohan Reddy T; Aparoy P; Achari C; Sridhar PR; Reddanna P
    Eur J Med Chem; 2012 Jan; 47(1):351-9. PubMed ID: 22118829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.